We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ZLAB market cap is 0. The company's latest EPS is USD and P/E is N/A.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 57.54M | 62.6M | 62.8M | 68.86M | 69.23M |
Operating Income | -128.58M | -96.82M | -69.52M | -99.5M | -83.57M |
Net Income | -161.19M | -61.77M | -49.14M | -120.9M | -69.15M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 12.99M | 48.96M | 144.31M | 215.04M | 266.72M |
Operating Income | -203.2M | -301.77M | -698.7M | -403.88M | -375.6M |
Net Income | -195.07M | -268.91M | -704.47M | -443.29M | -334.62M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.3B | 1.22B | 1.17B | 1.11B | 1.04B |
Total Liabilities | 192.65M | 174.55M | 168.83M | 174.06M | 162.72M |
Total Equity | 1.11B | 1.05B | 1B | 932.31M | 880.98M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 355.15M | 1.3B | 1.61B | 1.22B | 1.04B |
Total Liabilities | 60.49M | 128.29M | 230M | 174.55M | 240.18M |
Total Equity | 294.66M | 1.17B | 1.38B | 1.05B | 796.12M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -258.35M | -367.64M | -69.29M | -127.99M | -183.26M |
Investing | 424.39M | 420.02M | -53.95M | -11.25M | -25.23M |
Financing | -1.53M | -1.73M | -3.89M | -5.38M | -6.83M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -191.01M | -216.07M | -549.23M | -367.64M | -198.18M |
Investing | -14.89M | -554.83M | 249.96M | 420.02M | -10.78M |
Financing | 219.3M | 1.13B | 820.2M | -1.73M | -6.43M |
Market Cap | 0 |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 0 |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.34 (2.1%) |
Company Name | Zai Lab Ltd |
Address |
po box 311 george town 11205 |
Website | https://www.zailaboratory.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions